ELEVIDYS Kit Patient Weight 69.5 KG and above

RxCUI: 2641849
RxNorm name: ELEVIDYS Kit Patient Weight 69.5 KG and above
Display name: ELEVIDYS Kit Patient Weight 69.5 KG and above
Full name: ELEVIDYS Kit Patient Weight 69.5 KG and above
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:53

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
125781	ELEVIDYS	delandistrogene moxeparvovec-rokl	351(a)	Rx	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ELEVIDYS	DELANDISTROGENE MOXEPARVOVEC-ROKL	Sarepta Therapeutics, Inc.	3525abcd-fbd2-46c5-9706-cffdf2e8a361	2025-11-21	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2641849

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
3525abcd-fbd2-46c5-9706-cffdf2e8a361	ELEVIDYS Kit Patient Weight 69.5 KG and above	PSN	11	These highlights do not include all the information needed to use ELEVIDYS ® safely and effectively. See full prescribing information for ELEVIDYS. ELEVIDYS (delandistrogene moxeparvovec-rokl) suspension, for intravenous infusion Initial U.S. Approval: 2023	20251121
3525abcd-fbd2-46c5-9706-cffdf2e8a361	{70 (10 ML delandistrogene moxeparvovec-rokl 13300000000000 VECTOR-GENOMES/ML Injection [Elevidys]) } Pack [Elevidys Kit > 69.5 KG]	BPCK	11	These highlights do not include all the information needed to use ELEVIDYS ® safely and effectively. See full prescribing information for ELEVIDYS. ELEVIDYS (delandistrogene moxeparvovec-rokl) suspension, for intravenous infusion Initial U.S. Approval: 2023	20251121
3525abcd-fbd2-46c5-9706-cffdf2e8a361	Elevidys Kit Patient Weight 69.5 KG and above	SY	11	These highlights do not include all the information needed to use ELEVIDYS ® safely and effectively. See full prescribing information for ELEVIDYS. ELEVIDYS (delandistrogene moxeparvovec-rokl) suspension, for intravenous infusion Initial U.S. Approval: 2023	20251121